Home›Stocks›KRYS

KRYS — structural market context

Krystal Biotech, Inc. Common S

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

KRYS short interest & days to cover

SHARES SHORT

3.2M

% OF FLOAT

—

DAYS TO COVER

4.2

CHANGE VS PRIOR

-8.4%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (15d ago)

KRYS fails-to-deliver (FTD)

Settlement date	Failed shares	Price
2026-07-14 · 32d	5	$363.44
2026-07-09 · 37d	80	$375.4
2026-07-08 · 38d	19	$368.6

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

KRYS insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 8 sales

Insider	Type	Shares	Value	Filed
ROSSI DINO A · director	Sell (S)	341	$111K	2026-08-14
ROSSI DINO A · director	Sell (S)	2K	$747K	2026-08-14
ROSSI DINO A · director	Sell (S)	5K	$1.7M	2026-08-14
ROSSI DINO A · director	Sell (S)	2K	$554K	2026-08-14
ROSSI DINO A · director	Sell (S)	7K	$2.4M	2026-08-14

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying KRYS?

In the last 12 months of SEC Form 4 filings, KRYS recorded 0 open-market insider purchases and 8 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.

Is this page telling me to buy or sell KRYS?

No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.

All covered stocks Short Interest & FTD tracker Insider Buying tracker Analyst Accuracy tracker The platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.